Boston Scientific (BSX) Reports Mixed Q3 Results; Guides Q4
BSX Hot Sheet
EPS Growth %: +1,400.0%Financial Fact:
Net income (loss): 113M
Today's EPS Names:
TARO, BRLI, TLB, More
Boston Scientific Corporation (NYSE: BSX) reports Q3 adj-EPS of $0.19, 5 cents better than the analyst estimate of $0.14. Revenue for the quarter was $2.02 billion, which compares to the estimate of $2.04 billion.
Sees Q4 adj-EPS of $0.17-$0.21, on sales of $2.025-$2.125 billion. The Street is currently looking for Q4 EPS and sales of $0.17. and $2.10 billion, respectively.
Sees Q4 adj-EPS of $0.17-$0.21, on sales of $2.025-$2.125 billion. The Street is currently looking for Q4 EPS and sales of $0.17. and $2.10 billion, respectively.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- VeriFone Systems (PAY) Tops Q2 EPS by 3c; Guides Q3, FY12
- Flowers Foods, Inc. (FLO) Reports In-Line Q1 EPS; Adjusts FY12 EPS Growth Outlook
Create E-mail Alert Related Categories
Earnings, Guidance, Hot ListSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
